The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Mylan's revenues will grow 12.7% and EPS will grow 18.9%.
The average estimate for revenue is $1.72 billion. On the bottom line, the average EPS estimate is $0.63.
Last quarter, Mylan chalked up revenue of $1.81 billion. GAAP reported sales were 15% higher than the prior-year quarter's $1.58 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.83. GAAP EPS of $0.51 for Q3 were 42% higher than the prior-year quarter's $0.36 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 45.2%, 330 basis points better than the prior-year quarter. Operating margin was 21.6%, 360 basis points better than the prior-year quarter. Net margin was 11.7%, 180 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $6.80 billion. The average EPS estimate is $2.58.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 540 members out of 576 rating the stock outperform, and 36 members rating it underperform. Among 173 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 165 give Mylan a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mylan is outperform, with an average price target of $27.18.
- Add Mylan to My Watchlist.